1 Lam K, Sjauw KD, Henriques JP, Ince C, de Mol BAJM. Improved microcirculation in patients with ST-elevation myocardial infarctaion treated with the Impella LP2.5 percutaneous left ventricular assist device. Clin Res Cardiol. 2009;98:311–8,
2 den Uil CA, Akin S, Jewbali LS, dos Reis Miranda D, Brugts JJ, Constatninescu AA, et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic schock: a systematic review and met-analysis. Eur J Cardiothorac Surg. 2017;52:14–25.
3 Khalid N, Rogers T, Shlofmitz E, Chen Y, Khan JM, Musallam A, et al. Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: A retrospective analysis of the MAUDE database. EuroIntervention. 2019;15(1):44–6.
4 U. S. Food and Drug Administration. Summary of Safety and Effectiveness data (SSED): Impella Ventricular Support Systems, 2016.
5 Hildebrand R. Organe des Blutkreislaufs. In: Zilles K, Tillman BN. Anatomie. Heidelberg Berlin: Springer; 2010. p 323–54.
6 Gordon SR, Ivanov J, Cohen G and Ralph-Edwards A. Permanent cardiac pacing after a cardiac operation: Predicting the use of permanent pacemakers. Ann Thorac Surg. 1998; 66:1698–704.
7 Costa G, Zappulla P, Barbanti M, Cirasa A, Todaro D, Rapisarda G, et al. Pacemaker Dependency after Transcatheter Aortic Valve Implantation: Incidence, Predictors and Long-term outcomes. EuroIntervention. 2019;15(10):875–83.
8 Maan A, Refaat MM, Heist EK, Passeri, J, Inglessis I, Ptaszek L, et al. Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement. PACE. 2015;38:878–86.
9 Ali H, Furlanello F, Lupo P, Foresti S, de Amborggi G, Epicoc G, et al. Clinical and electrocardiographic features of complete hart block after blunt injury: A systematic review of the literature. Heart Rhythm. 2017;14(10):1561–659.